date:Mar 17, 2014
Ingredia has acquired Galactis Pharma shares, a company specialising in bioactive peptides for the pharmaceutical industry.
This acquisition is going to enable Ingredia to strengthen its position as a market leader in bioactive milk peptides by highlighting two of our recent patents, said Matthieu Arguillre, CEO of Ingredia.
Bioactive peptides are natural milk components carrying a range of health benefits, as demonstrated by research. These are said to include digestive health, stress managem